Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6XRM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $98,899
Award facts
- Contract value 100% obligated
- $98,898.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $98,898.60 on August 26, 2025, for the supply of Entyvio 300 mg vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and utilizes no set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 vehicle that enables the issuance of delivery orders for pharmaceutical products supporting military health facilities worldwide. Funding is provided through the Medical Supply Chain, a defense-focused federal agency.
This delivery order represents a continuation of DMS Pharmaceutical Group's role as a critical supplier in the federal pharmaceutical supply chain, providing prescription medications and biologics to Department of Defense healthcare sites. Entyvio is a gastrointestinal therapeutic agent used in the treatment of inflammatory bowel diseases, reflecting the comprehensive portfolio of specialty pharmaceutical products the company distributes to military medical facilities. The firm fixed-price structure ensures cost certainty for the government while DMS Pharmaceutical Group's established position as a trusted federal contractor with an extensive track record of pharmaceutical deliveries demonstrates its capability to fulfill this urgent requirement.
Quick answers
Who was awarded contract SPE2DX25F6XRM?
SPE2DX25F6XRM was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 26, 2025.
How much is contract SPE2DX25F6XRM worth?
The government has obligated $98,899 on SPE2DX25F6XRM.
Is contract SPE2DX25F6XRM an order under another contract?
Yes. SPE2DX25F6XRM is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRM competed?
The extent of competition for SPE2DX25F6XRM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award